Prescription of lipid-lowering therapy, LDLc control, and risk of MACE in patients after ST-elevation myocardial infarction in Mexico
Event:
ESC Acute CardioVascular Care 2024
Topic:
Secondary Prevention
Session:
Risk factors, prevention, and pharmacotherapy
